Corticosteroid-induced vasoconstriction studied by xenon 133 clearance.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D005260:Female; D005542:Forearm / Q000098:blood supply; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D008875:Middle Aged; D011868:Radioisotopes; D012039:Regional Blood Flow / Q000187:drug effects; D012867:Skin / Q000098:blood supply* / Q000187:drug effects; D014662:Vasoconstrictor Agents; D014978:Xenon
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011868:Radioisotopes; D014662:Vasoconstrictor Agents; D014978:Xenon